Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Functional Comparison of Different Tubes for Isolating Mononuclear Cells

By LabMedica International staff writers
Posted on 23 Apr 2020
Profiling of immune cells with single-cell technologies is a key component of both basic science studies, evaluation of therapeutics in clinical trials, and clinical care. More...
Cryopreserved human peripheral blood mononuclear cells (PBMCs) are a commonly used sample type for a variety of immunological assays.

Differences in PBMC sample processing techniques, including cryopreservation and thawing, can have a major influence on yield, viability, and in outcomes of downstream assays. Despite the near ubiquity of PBMC isolation, there is little standardization of processing methods across organizations and laboratories, and few studies have directly compared common differences in protocol steps.

Immunologists at Stanford University School of Medicine (Stanford, CA, USA) processed whole blood in parallel using both Cell Preparation Tubes (CPT, BD Biosciences, San Jose, CA, USA) and Lymphoprep Tubes (Axis-Shield, Dundee, UK) and assessed for yield and viability prior to cryopreservation. After thawing, samples were further examined by flow cytometry for cell yield, cell viability, frequency of 10 cell subsets, and capacity for stimulation-dependent CD4+ and CD8+ T cell intracellular cytokine production. Flow cytometry samples were acquired on a custom BD Biosciences’ 4-laser BD LSRII flow cytometer equipped with the BD FACSDiva Software.

To determine recovery rates, yield and viability of PBMCs isolated by both CPT and LP methods were verified immediately after PBMC isolation (fresh), as well as after cryopreservation for one month in liquid nitrogen. Viability was high for both methods with average values of 94.5% and 96.6% pre-freeze and 89.4% and 91.4% post-thaw for CPT and LP respectively. For each stimulation condition, there were no significant differences in the ratio of IFNγ, IL-4, and IL-17 positive T cells between the CPT or LP methods, indicating that both preserve a similar degree of T cell functionality after cryopreservation and recovery.

The potential bias of different PBMC processing methods for inadvertently depleting certain cell subsets (e.g. B cells) is a frequent point of concern when designing clinical studies. Therefore, flow cytometry was used to assess frequencies of 10 immune cell populations in PBMC samples isolated using CPT or LP methods. Frequencies of each population were not significantly different between the two isolation methods indicating no systematic loss of any cell type between CPT versus LP tubes.

The authors concluded that their results suggest that both CPT and LP Tubes are both effective methods of PBMC isolation that result in similar cell yield, viability, frequency of subsets, and capacity for stimulation-dependent T cell intracellular cytokine production. The study was published on March 30 2020 in the journal BMC Immunology.



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.